Related Experiment Video
Updated: Nov 25, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Voltage-dependent anion channels mediated apoptosis in refractory epilepsy
Yan Zhao1, Wen-Jing Jiang1, Lin Ma1
1Department of Geriatric Medicine, Shandong Key Laboratory of Cardiovascular Proteomics, Qilu Hospital of Shandong University, Jinan, 250012, Shandong Province, China.
Voltage-dependent anion channel 1 (VDAC1) significantly contributes to neuron apoptosis in refractory epilepsy by promoting the release of cytochrome C. Targeting VDAC1 may offer a new therapeutic strategy for epilepsy treatment.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Refractory epilepsy involves complex neuronal death pathways.
- Mitochondria-mediated apoptosis is implicated in neurological disorders.
- The role of specific channels in epilepsy-related apoptosis needs further elucidation.
Purpose of the Study:
- To investigate the function of voltage-dependent anion channel (VDAC) in mitochondria-mediated neuronal apoptosis in refractory epilepsy.
- To explore VDAC1's influence on key apoptotic factors like cytochrome C, caspase 9, Bax, and Bcl-2.
- To assess VDAC1 as a potential therapeutic target for refractory epilepsy.
Main Methods:
- Western blot analysis to quantify protein levels of cytochrome C, caspase 9, Bax, and Bcl-2.
- TUNEL assays to evaluate cell apoptosis.
- Experimental manipulation of VDAC1 expression (upregulation and downregulation) in neuronal models.
Main Results:
- VDAC1 upregulation correlated with increased levels of Bax, Bcl-2, and caspase 9.
- VDAC1 promoted the release of cytochrome C, indicating enhanced mitochondrial apoptosis.
- Modulation of VDAC1 significantly impacted apoptotic cell death in the context of refractory epilepsy.
Conclusions:
- VDAC1 plays a critical role in the apoptotic cell death of neurons in refractory epilepsy.
- VDAC1 influences the intrinsic apoptotic pathway by affecting Bax, Bcl-2, and caspase 9.
- VDAC1 represents a promising therapeutic target for developing novel anti-epileptic drugs.
More Related Videos
10:19Patch Clamp and Perfusion Techniques for Studying Ion Channels Expressed in Xenopus oocytes
Published on: January 10, 2011
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
The Role of Ion Channels in Neuronal Computation
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential....
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...